Tim M. Mayleben

2021 - Esperion Therapeutics

In 2021, Tim M. Mayleben earned a total compensation of $8.2M as Former Chief Executive Officer at Esperion Therapeutics, a 19% increase compared to previous year.

Compensation breakdown

Option Awards$3,986,245
Salary$265,152
Other$3,975,889
Total$8,227,286

Mayleben received $4M in option awards, accounting for 48% of the total pay in 2021.

Mayleben also received $265.2K in salary and $4M in other compensation.

Rankings

In 2021, Tim M. Mayleben's compensation ranked 1,394th out of 12,415 executives tracked by ExecPay. In other words, Mayleben earned more than 88.8% of executives.

ClassificationRankingPercentile
All
1,394
out of 12,415
89th
Division
Manufacturing
500
out of 5,505
91st
Major group
Chemicals And Allied Products
184
out of 2,375
92nd
Industry group
Drugs
153
out of 2,096
93rd
Industry
Pharmaceutical Preparations
102
out of 1,546
93rd

Pay ratio

Tim M. Mayleben's Pay$8,227,286
Median Employee's Pay$217,116
Pay Ratio

38

to 1

In 2021, the annual total compensation of Tim M. Mayleben was $8,227,286.

The annual total compensation of the median employee at Esperion Therapeutics was $217,116.

The ratio of Tim M. Mayleben's pay to the pay of median employee was therefore 38 to one.

Source: SEC filing on April 14, 2022.

Mayleben's colleagues

We found four more compensation records of executives who worked with Tim M. Mayleben at Esperion Therapeutics in 2021.

2021

Sheldon Koenig

Esperion Therapeutics

Chief Executive Officer

2021

JoAnne Foody

Esperion Therapeutics

Chief Medical Officer

2021

Richard Bartram

Esperion Therapeutics

Chief Financial Officer

2021

Ashley Hall

Esperion Therapeutics

Former Chief Development Officer

News

You may also like